An Exploration of Key Issues in IBD: A CME/CE-Certified Microlearning Series

Download All
In an engaging series of concise Medical Minute modules and ClinicalThought commentaries, learn how experts utilize current and emerging treatments for IBD and explore effective communication strategies for working with your patients toward shared decision-making.
Millie D. Long, MD, MPH
Bruce E. Sands, MD, MS

Early Induction Therapy for IBD

In this concise video, review a synthesis of recommendations from AGA and ACG guidelines on the treatment of moderate to severe UC and CD, and hear expert discussion on the rationale for early induction therapy with a biologic.

Bruce E. Sands, MD, MS Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: April 26, 2021 Expired: April 25, 2022

Learn about current guideline recommendations for the treatment of moderate to severe UC and CD, including the rationale for combination therapy.

Bruce E. Sands, MD, MS Released: April 26, 2021

With advances in novel biologic and small molecule treatment options, new diagnostics, and increasingly complex treatment algorithms, STRIDE-II extends on the previous STRIDE recommendations to help define reasonable treatment targets for IBD.

Bruce E. Sands, MD, MS Released: May 5, 2021

Next Steps Following TNF Inhibitor Failure in IBD

In this concise video, review recommendations for therapeutic drug monitoring of TNF-α inhibitor therapy and hear expert discussion of key data informing second-line treatment decisions of moderate to severe UC and CD following TNF-α inhibitor failure.

Bruce E. Sands, MD, MS Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: May 24, 2021 Expired: May 23, 2022

Learn about current guideline recommendations for therapeutic drug monitoring of TNF-α inhibitor therapy and review key data informing second-line treatment decisions of moderate to severe UC and CD following TNF-α inhibitor failure.

Bruce E. Sands, MD, MS Released: May 24, 2021

My take on TDM for patients receiving TNF-α inhibitors for IBD.

Bruce E. Sands, MD, MS Released: June 3, 2021

Listening to the Patient Perspective on IBD

In this concise video, gain expert insights on using shared decision-making with patients with IBD who are initiating biologic therapy and learn to effectively discuss data on malignancy risk associated with IBD therapies.

Millie D. Long, MD, MPH Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: June 23, 2021 Expired: June 22, 2022

Review best practices of shared-decision making and discussing risk of cancer when discussing initiation of biologic therapy with patients who have IBD.

Millie D. Long, MD, MPH Released: June 24, 2021

“Activated” patients with IBD understand their care and have the skills and confidence to manage its intricacies. They also have better outcomes.

Millie D. Long, MD, MPH Released: July 13, 2021
Provided by Clinical Care Options

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie
Bristol-Myers Squibb

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue